Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Long Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED) [Phase 3]
Phase 3 trial evaluating long-term treatment with MK0869 for Major Depressive Disorder has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Treatment of Patients With Major Depressive Disorder With MK0869 (0869-073) [Phase 3]
Phase 3 clinical trial evaluating MK0869 (0869-073) for Major Depressive Disorder has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Treatment of Patients With Major Depressive Disorder With MK0869 (0869-063) [Phase 3]
Phase 3 study of MK0869 (0869-063) for major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED) [Phase 3]
A Phase 3 trial evaluating MK0869 for major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Treatment of Patients With Major Depressive Disorder With MK0869 (0869-068)(COMPLETED) [Phase 3]
Phase 3 trial evaluating MK0869 for major depressive disorder has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-05-04FDA Approved: APLENZIN — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental NDA for APLENZIN (bupropion hydrobromide) from Bausch Health US, LLC. The approval involves a supplemental submi…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Can Mental Health Apps Work in the Real World? A Feasibility Pilot Study. [NA]
A feasibility pilot study evaluated the real-world use of mental health apps for major depressive disorder; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: The Effect of a Selective Serotonin Reuptake Inhibitor on Gait, Balance, and Bone Metabolism in Older Adults [Phase 4]
A Phase 4 study evaluated whether a selective serotonin reuptake inhibitor affects gait, balance, and bone metabolism in older adults with d…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Evaluation of Pharmacogenetic Testing In a Mental Health Population and Economic Outcomes
This update reports on a completed clinical trial evaluating pharmacogenetic testing in people with Major Depressive Disorder and its econom…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Past Pain Experience and Perception of Experimental Pain
This completed clinical trial investigated how past pain experience relates to perceptions of experimental pain in individuals with schizoph…
-
CLINICAL_TRIALS research · 2017-05-03Clinical Trial Update: Pharmacogenetic Testing on an Outpatient Population With a Depression Diagnosis [NA]
A completed clinical trial evaluated pharmacogenetic testing in outpatients diagnosed with major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Behavioral Activation - From Inpatient to Outpatient Services [NA]
A completed clinical trial evaluating behavioral activation for transitioning from inpatient to outpatient services in individuals with depr…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Pharmacogenetic Testing in an Outpatient Population of Patients With Depression [NA]
This entry indicates the completion of a clinical trial evaluating pharmacogenetic testing in outpatients with depression.
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Vortioxetine for Menopausal Depression [Phase 4]
Phase 4 trial of vortioxetine for menopausal depression completed with results posted in May 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: A Comparison of Cognitive and Dynamic Therapy for Depression in Community Settings [NA]
This clinical trial update reports on a completed study comparing cognitive therapy and dynamic therapy for Major Depressive Disorder in com…
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: The Efficacy of Cranial Electrostimulating Therapy for Depression and Anxiety Among Homeless Adults [NA]
Completed clinical trial evaluating cranial electrostimulation therapy for depression and anxiety in homeless adults; results posted in 2017…
-
CLINICAL_TRIALS research · 2017-05-01Clinical Trial Update: Reaching Out to Adolescents With Depression [NA]
An update on a clinical trial involving outreach to adolescents with depression. The trial status is completed and no specific drug details …
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Does Fish Oil Prevent Depression in Pregnancy and Postpartum? [Phase 2, Phase 3]
A Phase 2/Phase 3 trial studied whether fish oil supplementation prevents depression during pregnancy and after childbirth; results have bee…
-
FDA approval · 2017-04-28FDA Approved: PAROXETINE — Supplemental Application (Padagis US LLC)
The FDA has approved a supplemental application for paroxetine filed by Padagis US LLC. This notice indicates FDA approval of an amendment t…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: The Role of Cytokine-Serotonin Interactions in Post-Stroke Depression [Phase 4]
A Phase 4 clinical trial evaluating cytokine-serotonin interactions in post-stroke depression has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Adjunctive Brief Behavioral Treatment of Insomnia (BBTI) for Sleep Intervention (SI) [NA]
This update summarizes the completion of a study evaluating adjunctive Brief Behavioral Treatment of Insomnia (BBTI) for sleep problems, wit…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Treating Depression in Coronary Artery Disease With Omega-3 Fatty Acids [Phase 3]
Phase 3 trial evaluating omega-3 fatty acids for depression in patients with coronary artery disease has completed. The update does not incl…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Open Trial Determining Antidepressant Effects of Omega-3 Supplementation During Pregnancy [EARLY_Phase 1]
The clinical trial update indicates an early-phase 1 study evaluating the antidepressant effects of omega-3 fatty acid supplementation durin…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Cytokines, PUFA Tissue Concentrations and Treatment Selection in Antenatal MDD [EARLY_Phase 1]
The EARLY_PHASE1 clinical trial evaluating cytokines, PUFA tissue concentrations, and treatment selection for major depressive disorder duri…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Depression and Traumatic Brain Injury [Phase 4]
A Phase 4 clinical trial evaluating treatments for depression and traumatic brain injury has completed, sponsored by Sunnybrook Health Scien…